Navigation Links
Ausio Pharmaceuticals to Present at Bio(R) 2009
Date:5/14/2009

Initial results from preclinical and Phase 1 safety studies, and plans for Phase 2 studies for menopausal symptoms and benign prostatic hyperplasia (BPH) are to be presented

CINCINNATI, May 14 /PRNewswire/ -- Ausio Pharmaceuticals, LLC, a biotechnology development company focused on medicines for an aging global population, will lead off the Bio(R) Business Forum in a presentation on May 19, 2009 at 9:00 AM in Atlanta, Georgia. Ausio has developed AUS-131, a pharmaceutical formulation of the soy metabolite S-equol. AUS-131 is expected to provide soy health benefits by consistently delivering therapeutically appropriate levels of S-equol, validated in clinical trial programs. Ausio has successfully completed two Phase 1 clinical trials for AUS-131, and Phase 2 studies are scheduled for treatment of menopausal symptoms and BPH.

AUS-131 Preclinical and Phase 1 Clinical Results

AUS-131 is pure, synthetic S-equol, a soy metabolite, and acts as a nonsteroidal, nonhormonal, selective estrogen receptor beta (ER beta) agonist. The safety profile of AUS-131 in FDA-required preclinical studies was excellent, and AUS-131 has demonstrated positive effects in rodent models of menopausal hot flashes and BPH, supporting its promise for the treatment of these conditions in humans. In Phase 1 trials, AUS-131 demonstrated a favorable safety and pharmacokinetic profile, with no significant drug-related adverse events at doses several-fold higher than the expected therapeutic range.

Phase 2 clinical trials to assess the efficacy of AUS-131 for relief of menopausal symptoms and BPH are on schedule to begin September 2009. The expected completion date for the Phase 2 clinical trials is Q2 2010.

About AUS-131

AUS-131 is pure, synthetic S-equol, a potent metabolite of the soy isoflavone, daidzein, which is produced in only a subset of individuals. AUS-131 is a first-in-class
'/>"/>

SOURCE Ausio Pharmaceuticals, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... Until recently, pets suffering from arthritic ailments had ... pain. Pill therapies are costly, can be harmful to ... , The procedure uses adult (not embryonic) animal stem ... healing power. MediVet's equipment enable veterinarians to remove a ... cells, then activate and inject the cells into the ...
(Date:9/11/2014)... 11, 2014 Europe ... of its biocompatible, non-toxic and non-leaching antimicrobial Sanipolymers™. Parx ... one of the top tech startups of ... to create antimicrobial plastics. Consumers are becoming ... surfaces use hazardous substances. These substances or additives can ...
(Date:9/11/2014)... Follow us on LinkedIn ... launch of a major research program analysing the ... to participate in this comprehensive grassroots level global ... technologists and market strategists. The new report to ... global market developments including major technologies, trends and ...
(Date:9/11/2014)... 2014 The Remedy Group , ... managed care organizations, has announced that Terry Souwannamuang has ... his years in biopharma and managed care Terry steadily ... starting a brand new specialty pharmacy for a Portland-based ... is unparalleled. Terry has a Bachelor’s Degree in General ...
Breaking Biology Technology:MediVet America Secures Exclusive Worldwide License with Nanofiber Veterinary 2World's First Biocompatible and Non-toxic Antibacterial Plastic 2Growing Per Capita Meat Consumption Drives Growth in the Global Feed Acidifiers Market, According to an Upcoming Report by Global Industry Analysts, Inc. 2Growing Per Capita Meat Consumption Drives Growth in the Global Feed Acidifiers Market, According to an Upcoming Report by Global Industry Analysts, Inc. 3The Remedy Group Announces Hiring of Managed Care and Specialty Pharmacy Veteran 2
... 22 GeneGo, Inc., a leading provider of software ... , today announced that the University of Cardiff has ... researchers will have access to GeneGo,s MetaCore, training and ... their partner relationship with GeneGo to provide a pathway ...
... firm, SiliconSky GPS, designs and develops a GPS-enabled asthma inhaler that ... triggers. , ... Red Lodge, MT (PRWEB) April 22, ... and product design firm, announced today that is has successfully completed ...
... Manufacturers of America (PhRMA) and the national consumer health ... three key policies designed to help achieve high-quality, affordable ... will work together and will reach out to other ... the healthcare reform proposals to be considered this year. ...
Cached Biology Technology:Cardiff University Becomes a GeneGo Center of Excellence 2SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program 2SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program 3PhRMA, Families USA Jointly Promote Measures to Ensure Quality, Affordable Healthcare Coverage 2PhRMA, Families USA Jointly Promote Measures to Ensure Quality, Affordable Healthcare Coverage 3
(Date:9/12/2014)... September 12, 2014 ... the addition of the  "Global Facial Recognition ... and Facial Analytics) - Industry Analysis, Size, ... 2020"  report to their offering. ... facial recognition market was valued at USD ...
(Date:9/12/2014)... by City College of New York biologist Mike Hickerson, a ... that explains how so many species of birds ended up ... from Mexico to the southernmost tip of South America. It ... "The unanswered question has beenhow did this extraordinary bird diversity ... on the subject published in the journal Nature ...
(Date:9/12/2014)... displacing data storage and processing from the user,s computer ... more storage space and computing power that they can ... having to connect to a single desktop or other ... raised concerns about the increased energy demands of sustaining ... where an individual user,s laptop might be shut down ...
Breaking Biology News(10 mins):Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 3Cutting the cloud computing carbon cost 2
... Annual Meeting & OTO EXPO of the American Academy of ... meeting of ear, nose, and throat doctors in the world, ... Featuring more than 305 scientific research sessions, 594 posters, and ... is a unique opportunity for journalists from around the world ...
... by a North Carolina State University researcher has shown ... act like solar cells to produce electricity. The findings ... closely mimic nature. They also have the potential to ... current standard-bearer: silicon-based solar cells. The bendable devices ...
... study has determined that teenagers who have abortions are no ... their peers whose pregnancies do not end in abortion. ... University of California, San Francisco, is the first to use ... representative sample of adolescents. The researchers found that young ...
Cached Biology News:2010 AAO-HNSF miniseminars: Sunday, Sept. 26, 2010 22010 AAO-HNSF miniseminars: Sunday, Sept. 26, 2010 3Mimicking nature, water-based 'artificial leaf' produces electricity 2National study: Abortion does not cause depression or low self-esteem in adolescents 2National study: Abortion does not cause depression or low self-esteem in adolescents 3
... 'Agilents GeneSpring Workgroup solution is ... managing and mining expression data in ... and is deployed in over 40 ... research organizations worldwide. GeneSpring Workgroup streamlines ...
... Best: DASGIPs Process Control integrates Process ... comprehensive documentation for cultivation processes. A ... pH, dissolved oxygen, temperature and agitation ... Profiles, e.g. constant or scheduled media ...
... a genome-wide microRNA (miRNA) expression profiling service ... which enable highly sensitive and specific direct ... arrays for mature miRNA of all species ... Sanger miRBase database (Release 8.2). Our service ...
... PEP-165 is an 18 amino acid synthetic peptide whose sequences are ... is (amino to carboxy terminus): S(21) - S - M - ... - E - A - I - D - K - ... This peptide may be used for neutralization and control ...
Biology Products: